Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Shanghai Huaota Biopharmaceutical Co., Ltd.

Clinical trials sponsored by Shanghai Huaota Biopharmaceutical Co., Ltd., explained in plain language.

Upcoming readouts

Trials from this sponsor expected to report results within the next 12 months.

New antibody shot could tackle stubborn acne Results expected Oct 2026 (estimated)

Browse trials soon ready across all sponsors →

Trials to join now! 2 Not yet recruiting 3 Completed 1

New antibody drug HB0043 gets first human safety check

Knowledge-focused Completed

This study tested the safety and tolerability of a single dose of HB0043, a lab-made antibody that targets two inflammatory proteins (IL-17A and IL-36R), in 52 healthy adults aged 18 to 55. Participants received either the drug or a placebo, and researchers monitored for side eff…

Phase 1 • Sponsor: Shanghai Huaota Biopharmaceutical Co., Ltd. • Aim: Knowledge-focused

Last updated Jun 27, 2026 14:00 UTC